Patents by Inventor Danny Belkin

Danny Belkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • In vitro techniques for use with stem cells
    Patent number: 8685724
    Abstract: A method is provided for use with extracted blood, including (a) applying blood to a first gradient suitable for selecting first-pass cells having a density less than 1.077 g/ml; (b) applying the first-pass cells to a second gradient suitable for selecting second-pass cells having a density between 1.055 and 1.074 g/ml; (c) increasing the number of cells having a density between 1.055 and 1.074 g/ml, by culturing the second-pass cells for a period lasting between 3 and 30 days; and (d) identifying endothelial progenitor cells in the cultured cells. Other embodiments are also described.
    Type: Grant
    Filed: June 1, 2005
    Date of Patent: April 1, 2014
    Assignee: Kwalata Trading Limited
    Inventors: Valentin Fulga, Yael Porat, Danny Belkin, Daphna Shimoni-Zalk, Svetlana Porozov
  • Automated Cell Therapy System
    Publication number: 20110206643
    Abstract: A method for automated cell processing is provided, including receiving at least one tissue containing a multiplicity of cells belonging to multiple cell types, and automatically increasing both the proportion of cells of at least one of said multiple cell types as compared with at least another of said multiple cell types and the absolute number of cells of said at least one of said multiple cell types. Other embodiments are also described.
    Type: Application
    Filed: May 31, 2006
    Publication date: August 25, 2011
    Applicants: IN MOTION INVESTMENT, LTD.
    Inventors: Valentin Fulga, Robert Michael Clark, Yael Porat, Danny Belkin, Avner Schrift, Eyal Teichman
  • In Vitro Techniques For Use With Stem Cells
    Publication number: 20080220466
    Abstract: A method is provided for use with extracted blood, including (a) applying blood to a first gradient suitable for selecting first-pass cells having a density less than 1.077 g/ml; (b) applying the first-pass cells to a second gradient suitable for selecting second-pass cells having a density between 1.055 and 1.074 g/ml; (c) increasing the number of cells having a density between 1.055 and 1.074 g/ml, by culturing the second-pass cells for a period lasting between 3 and 30 days; and (d) identifying endothelial progenitor cells in the cultured cells. Other embodiments are also described.
    Type: Application
    Filed: June 1, 2005
    Publication date: September 11, 2008
    Inventors: Valentin Fulga, Yael Porat, Danny Belkin, Daphna Shimoni-Zalk, Svetlana Porozov